Biochip is a miniaturized medical device, which performs several biochemical reactions. This device is a collection of microarrays or micro-test strips that are arranged on the surface of chip, and are meant to perform multiple tests simultaneously. Biochip is extremely small in size ranging from 2 inches to 12 inches. These chips can perform various biotechnology applications such as decoding genes and searching for contaminations in the sample in a few seconds.
The global biochips market was valued at $9,037 million in 2017, and is projected to reach $21,419 million by 2025 at a CAGR of 11.2% from 2018 to 2025. Factors such as rise in prevalence of various life-threatening diseases increases the demand for disease diagnostics, which in turn drives the growth of the global biochips market. Moreover, rise in adoption of personalized medicines and presence of large geriatric population boost the market growth. However, lack of knowledge related to biochips and their high cost of hamper the market growth. Conversely, huge untapped potential in the emerging countries, such as China and India, and rise in R&D investment as well as government funding are expected to offer lucrative opportunities to the market players.
Major Key Players of the Biochips Market are:bioMérieux SA, Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Fluidigm Corporation, HORIBA, Ltd., Illumina, Inc., PerkinElmer, Inc., QIAGEN N.V., Randox Laboratories Ltd., Thermo Fisher Scientific Inc.
Read More @ http://www.sbwire.com/press-releases/biochips-market-to-witness-robust-expansion-throughout-the-forecast-period-2018-2025-biomrieux-sa-bio-rad-laboratories-f-hoffmann-la-roche-1287080.htm
The global biochips market was valued at $9,037 million in 2017, and is projected to reach $21,419 million by 2025 at a CAGR of 11.2% from 2018 to 2025. Factors such as rise in prevalence of various life-threatening diseases increases the demand for disease diagnostics, which in turn drives the growth of the global biochips market. Moreover, rise in adoption of personalized medicines and presence of large geriatric population boost the market growth. However, lack of knowledge related to biochips and their high cost of hamper the market growth. Conversely, huge untapped potential in the emerging countries, such as China and India, and rise in R&D investment as well as government funding are expected to offer lucrative opportunities to the market players.
Major Key Players of the Biochips Market are:bioMérieux SA, Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Fluidigm Corporation, HORIBA, Ltd., Illumina, Inc., PerkinElmer, Inc., QIAGEN N.V., Randox Laboratories Ltd., Thermo Fisher Scientific Inc.
Read More @ http://www.sbwire.com/press-releases/biochips-market-to-witness-robust-expansion-throughout-the-forecast-period-2018-2025-biomrieux-sa-bio-rad-laboratories-f-hoffmann-la-roche-1287080.htm
No comments:
Post a Comment